Related references
Note: Only part of the references are listed.High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients
Longxiang Xie et al.
GENES (2019)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns
Xiangqian Guo et al.
BMC GENOMICS (2018)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset
Woonyoung Choi et al.
EUROPEAN UROLOGY (2017)
Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
Owen T. M. Chan et al.
ONCOTARGET (2017)
Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy
Pengjie Wu et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Margaret A. Knowles et al.
NATURE REVIEWS CANCER (2015)
Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder
Nikhil Sapre et al.
PATHOLOGY (2014)
USP28 is a potential prognostic marker for bladder cancer
Guiying Guo et al.
TUMOR BIOLOGY (2014)
FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy
Ji-Youn Sung et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder
Evanguelos Xylinas et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
George J. Netto
NATURE REVIEWS UROLOGY (2012)
Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2
Anis Aziz et al.
BJU INTERNATIONAL (2011)
Association of Hyaluronic Acid Family Members (HAS1, HAS2, and HYAL-1) With Bladder Cancer Diagnosis and Prognosis
Mario W. Kramer et al.
CANCER (2011)
High Expression of Karyopherin-α2 Defines Poor Prognosis in Non-Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy
Jorgen Bjerggaard Jensen et al.
EUROPEAN UROLOGY (2011)
Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder
Ramy F. Youssef et al.
HUMAN PATHOLOGY (2011)
Role of Androgen Receptor and Associated Lysine-Demethylase Coregulators, LSD1 and JMJD2A, in Localized and Advanced Human Bladder Cancer
Eric C. Kauffman et al.
MOLECULAR CARCINOGENESIS (2011)
Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patients
Lauren C. Harshman et al.
BJU INTERNATIONAL (2010)
Expression Status and Prognostic Significance of Mammalian Target of Rapamycin Pathway Members in Urothelial Carcinoma of Urinary Bladder After Cystectomy
Luciana Schultz et al.
CANCER (2010)
Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy
Yoichi Mizutani et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance
Georgia Levidou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
The prognostic value of cadherin switch in bladder cancer
Tobias Jaeger et al.
ONCOLOGY REPORTS (2010)
Galectin-3 expression is associated with bladder cancer progression and clinical outcome
Giacomo Canesin et al.
TUMOR BIOLOGY (2010)
Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use
Christian Bolenz et al.
NATURE CLINICAL PRACTICE UROLOGY (2008)
Smoking and bladder cancer in Spain:: Effects of tobacco type, timing, environmental tobacco smoke, and gender
Claudine Samanic et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy
Y Lotan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Urine markers for bladder cancer surveillance: A systematic review
BWG van Rhijn et al.
EUROPEAN UROLOGY (2005)
Share Paper
